Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.
Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.
Diluvio
Laura
L
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. lauradiluvio@yahoo.it
Campione
Elena
E
Paternò
Evelin J
EJ
Mordenti
Cristina
C
El Hachem
Maya
M
Chimenti
Sergio
S
D002648:Child; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids
D003879:Dermatologic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids